CHEMICAL PREPARATIONS GENE THERAPY

Brand Owner Address Description
AAV 3.0 THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 3451 Walnut Street, Suite 737 Philadelphia PA 19104 Chemical preparations for gene therapy for treating genetic disorders; viral medicines; gene therapy medicines; nucleic acid delivery medicines; viral vector manufacturing preparations for use in gene delivery; pharmaceutical and biochemical preparations for use in nucleic acid-based therapy, gene therapy and cell therapy in the treatment of human diseases;AAV THREE POINT 0;Gene therapy assays; gene therapy reagents; gene therapy preparations; nucleic acid delivery assays; nucleic acid delivery reagents; nucleic acid delivery preparations; viral vectors; gene therapy vectors; nucleic acid delivery vectors; cells and tissues transformed by viral vectors, gene therapy vectors, and nucleic acid delivery vectors;Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of human diseases;AAV;Testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific and medical research and development, namely, laboratory research in the field of gene therapy vectors for medical and research purposes; genetic engineering biotechnology services, namely, research and development of new technology in the field of biotechnology; product development services related to gene therapy products and instruments; consultation services in the fields of medical and scientific research in the field of gene therapy;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A nucleic acid encoding a promoter and comprising a nucleic acid sequence of SEQ ID NO:1, fragments and/or variants thereof, for use in gene therapy derived from the Herpesvirus saimiri (HVS) ORF73 (ECLFI) gene. The invention also includes a gene therapy system and an HVS vector system including the promoter.